1. Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
- Author
-
Heudel, P., primary, Chabaud, S., additional, Perol, D., additional, Flechon, A., additional, Fayette, J., additional, Combemale, P., additional, Tredan, O., additional, Desseigne, F., additional, de la Fouchardiere, C., additional, Boyle, H., additional, Perol, M., additional, Bachelot, T., additional, Cassier, P., additional, Avrillon, V., additional, Terret, C., additional, Michallet, A.-S., additional, Neidhardt-Berard, E.-M., additional, Nicolas-Virelizier, E., additional, Dufresne, A., additional, Belhabri, A., additional, Brahmi, M., additional, Lebras, L., additional, Nicolini, F., additional, Sarabi, M., additional, Rey, P., additional, Bonneville-Levard, A., additional, Rochefort, P., additional, Provensal, A.-M., additional, Eberst, L., additional, Assaad, S., additional, Swalduz, A., additional, Saintigny, P., additional, Toussaint, P., additional, Guillermin, Y., additional, Castets, M., additional, Coutzac, C., additional, Meeus, P., additional, Dupré, A., additional, Durand, T., additional, Crochet, H., additional, Fervers, B., additional, Gomez, F., additional, Rivoire, M., additional, Gregoire, V., additional, Claude, L., additional, Chassagne-Clement, C., additional, Pilleul, F., additional, Mognetti, T., additional, Russias, B., additional, Soubirou, J.-L., additional, Lasset, C., additional, Chvetzoff, G., additional, Mehlen, P., additional, Beaupère, S., additional, Zrounba, P., additional, Ray-Coquard, I., additional, and Blay, J.-Y., additional
- Published
- 2021
- Full Text
- View/download PDF